Related Experiment Video

Updated: Nov 10, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.8K

Nucleotide prodrugs for the treatment of HCV infection

Michael J Sofia1

  • 1OnCore Biopharma, Inc., Doylestown, Pennsylvania, USA. mikes@oncorebiopharma.com

Advances in Pharmacology (San Diego, Calif.)
|July 27, 2013
PubMed

Insights

Nucleotide prodrugs show promise for treating Hepatitis C virus (HCV) infections. These potent inhibitors, when combined with other antivirals, achieve high cure rates and offer interferon-free treatment options.

Area of Science:

  • Virology
  • Hepatology
  • Medicinal Chemistry

Background:

  • Hepatitis C virus (HCV) RNA-dependent RNA polymerase is a key target for antiviral therapies.
  • Nucleoside and nucleotide inhibitors are explored for pangenotypic activity and high resistance barrier.
  • Nucleoside inhibitors showed clinical efficacy but were limited by potency.

Purpose of the Study:

  • To evaluate the efficacy of nucleotide prodrugs as potential therapies for HCV.
  • To assess the liver-targeting and oral administration characteristics of these nucleotide prodrugs.
  • To explore combination therapies involving nucleotide prodrugs for HCV treatment.

Main Methods:

  • Development of nucleoside 5'-monophosphate prodrug strategies.
  • Evaluation of liver-targeting properties upon oral administration.
  • Clinical studies assessing viral load reduction and cure rates in HCV patients.

Main Results:

  • Nucleotide prodrugs demonstrated potent inhibition of HCV replication.
  • Oral administration of nucleotide prodrugs showed liver-targeting characteristics.
  • Combination therapies with nucleotide prodrugs achieved up to 100% cure rates in 12 weeks.
  • Significant reductions in viral load were observed in human clinical studies.

Conclusions:

  • Nucleotide prodrugs represent a highly effective strategy for HCV treatment.
  • These agents offer potential for oral administration and liver targeting.
  • Combination therapy with nucleotide prodrugs can lead to interferon-free regimens and high cure rates for HCV patients.
Keywords:
Hepatitis C virusNS5B inhibitorsNucleosidesNucleotidesPhosphate prodrugs

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

8.1K
A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.5K

Related Concept Videos

Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
277
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
335
Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
3.5K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.2K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
311
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.5K